- Home
- RANG vs ALDX Comparison
RANG vs ALDX Comparison
Compare RANG & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANG
- ALDX
- Stock Information
- Founded
- RANG 2024
- ALDX 2004
- Country
- RANG United States
- ALDX United States
- Employees
- RANG N/A
- ALDX N/A
- Industry
- RANG
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- RANG
- ALDX Health Care
- Exchange
- RANG Nasdaq
- ALDX Nasdaq
- Market Cap
- RANG 165.2M
- ALDX 133.7M
- IPO Year
- RANG 2024
- ALDX 2014
- Fundamental
- Price
- RANG $10.14
- ALDX $2.15
- Analyst Decision
- RANG
- ALDX Strong Buy
- Analyst Count
- RANG 0
- ALDX 2
- Target Price
- RANG N/A
- ALDX $9.50
- AVG Volume (30 Days)
- RANG 5.8K
- ALDX 1.2M
- Earning Date
- RANG 01-01-0001
- ALDX 05-14-2025
- Dividend Yield
- RANG N/A
- ALDX N/A
- EPS Growth
- RANG N/A
- ALDX N/A
- EPS
- RANG N/A
- ALDX N/A
- Revenue
- RANG N/A
- ALDX N/A
- Revenue This Year
- RANG N/A
- ALDX N/A
- Revenue Next Year
- RANG N/A
- ALDX N/A
- P/E Ratio
- RANG N/A
- ALDX N/A
- Revenue Growth
- RANG N/A
- ALDX N/A
- 52 Week Low
- RANG $9.91
- ALDX $1.14
- 52 Week High
- RANG $10.64
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- RANG N/A
- ALDX 38.93
- Support Level
- RANG N/A
- ALDX $2.15
- Resistance Level
- RANG N/A
- ALDX $2.30
- Average True Range (ATR)
- RANG 0.00
- ALDX 0.15
- MACD
- RANG 0.00
- ALDX 0.06
- Stochastic Oscillator
- RANG 0.00
- ALDX 37.93
About RANG Range Capital Acquisition Corp. Ordinary Shares
Range Capital Acquisition Corp is a blank check company.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.